title: Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women.
abstract: Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and müllerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.
authors.affiliation: Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11219, USA. drfaisalaslam@yahoo.co.uk
authors.forename: Muhammad Faisal
authors.initials: MF
authors.lastname: Aslam
authors.forename: Zaher O
authors.initials: ZO
authors.lastname: Merhi
authors.forename: Safaa
authors.initials: S
authors.lastname: Ahmed
authors.forename: Oumar
authors.initials: O
authors.lastname: Kuzbari
authors.forename: David B
authors.initials: DB
authors.lastname: Seifer
authors.forename: Howard
authors.initials: H
authors.lastname: Minkoff
mesh_terms: D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood*; D005260:Female; D006801:Humans; D016555:Matched-Pair Analysis; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000534:rehabilitation; D017697:Premenopause / Q000097:blood*; D055815:Young Adult
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D054304:Anti-Mullerian Hormone